This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Enerpac Tool (EPAC) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Enerpac Tool (EPAC) Q4 results reflect the impact of weak sales generation due to the pandemic as well as a decline in margins. Projections remain suspended on prevailing uncertainties.
Enerpac (EPAC) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Enerpac (EPAC) delivered earnings and revenue surprises of -71.43% and -6.83%, respectively, for the quarter ended August 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Enerpac (EPAC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Enerpac (EPAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stanley Black Shares Gain 23% in 3 Months: What's Driving It?
by Zacks Equity Research
Stanley Black (SWK), with a three-month rise of 23% in shares, benefits from a solid product portfolio, surge in e-commerce and reviving U.S. manufacturing. Cost actions and dividend hike also aid.
2 Manufacturing Tool Stocks to Watch Out For Amid Pandemic
by Payal Jalan
Despite recovery in manufacturing and growing e-commerce, the pandemic-led end-market challenges and high debt levels restrict the Zacks Manufacturing-Tools & Related Products industry's growth. Two stocks to watch out for are SWK and LECO.
Enerpac Gains From Solid Product Portfoilo Amid Pandemic Woes
by Zacks Equity Research
Enerpac Tool (EPAC) gains from strong product portfolio, focus on growth initiatives, acquisition and shareholder-friendly policies. Pandemic-led uncertainties and high debt persist.
Enerpac (EPAC) Up 15.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Enerpac (EPAC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Enerpac's Products & Cost-Saving Moves to Aid Amid Pandemic
by Zacks Equity Research
Enerpac's (EPAC) efforts to introduce new products as well as its cost-savings actions are likely to aid, especially in the present uncertainties caused by the coronavirus outbreak.
Enerpac Tool (EPAC) Swings to Loss in Q3, Revenues Decline Y/Y
by Zacks Equity Research
Enerpac Tool (EPAC) Q3 results reflect pandemic-related headwinds on sales, operating and bottom-line operating performances. Projections remain suspended on prevailing uncertainties.
Enerpac Tool Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Enerpac Tool Group has been struggling lately, but the selling pressure may be coming to an end soon.
Enerpac (EPAC) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Enerpac (EPAC) delivered earnings and revenue surprises of -150.00% and -15.47%, respectively, for the quarter ended May 2020. Do the numbers hold clues to what lies ahead for the stock?
Micron (MU) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Work-and-learn from home wave amid coronavirus pandemic spurs significant chip demand from PC manufacturers and data-center operators, which is expected to have driven Micron's (MU) Q3 earnings.
BlackBerry (BB) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
BlackBerry's (BB) first-quarter fiscal 2021 results are likely to reflect the impact of COVID-19 on its business as well as in the global auto production and sales.
SYNNEX (SNX) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Slowdown in technology spending by enterprises and supply-chain disruptions due to the coronavirus outbreak might have affected SYNNEX's (SNX) Q2 performance.
Enerpac (EPAC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Enerpac (EPAC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Commercial Metals' (CMC) Q3 Earnings?
by Zacks Equity Research
Commercial Metals' (CMC) Q3 results will likely reflect improved domestic construction markets, offset by lower steel prices due to the coronavirus pandemic.
Enerpac Tool (EPAC) to Redeem Notes, Lower Interest Expenses
by Zacks Equity Research
Enerpac Tool's (EPAC) voluntary redemption of 5.625% senior notes will help it lower its annual interest expenses by $10 million.
Coronavirus Dims Manufacturing Tools Stocks' Near-Term Outlook
by Payal Jalan
The end-market weakness and global uncertainties due to the coronavirus outbreak blurs prospects of manufacturing industrial tool makers. However, a solid liquidity position and cost-reduction measures might aid the players.
Reasons Why Stanley Black (SWK) Should Be Avoided for Now
by Zacks Equity Research
Stanley Black's (SWK) revenue-generation capabilities are severely hurt on coronavirus concerns. Further, high debts and forex woes might be dragging.
Enerpac Highlights Business Actions Amid Coronavirus Concern
by Zacks Equity Research
Enerpac (EPAC) highlights several actions to maintain a healthy capital structure amid the coronavirus outbreak.
Enerpac Tool Declines 36% YTD: What's Hurting the Stock?
by Zacks Equity Research
Enerpac Tool (EPAC), with a 36% decline in shares so far in 2020, faces headwinds from volatile oil prices and the adverse impacts of the coronavirus outbreak. It suspends projections for fiscal 2020.
Stanley Black & Decker Declines 42% YTD: What's Hurting It?
by Zacks Equity Research
Stanley Black & Decker (SWK), with shares down 42% so far in 2020, faces risks from difficult end-market conditions and external woes. The virus outbreak is also likely to hamper revenue generation.
Enerpac Tool (EPAC) Lags on Q2 Earnings, Discontinues View
by Zacks Equity Research
Enerpac Tool (EPAC) Q2 results reflect weak sales and operating performance. It discontinues the fiscal 2020 projections due to volatility in oil prices and the coronavirus outbreak.
Actuant (EPAC) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Actuant (EPAC) delivered earnings and revenue surprises of -25.00% and -2.78%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Actuant (EPAC) Q2 Earnings Expected to Decline
by Zacks Equity Research
Actuant (EPAC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.